White matter abnormalities associated with Alzheimer’s disease and mild cognitive impairment: a critical review of MRI studies

References

• Dubois B, Feldman HH, Jacova C et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol. 9(11), 1118–1127 (2010).
   PubMed Web of Science ®Google Scholar
• Sperling RA, Aisen PS, Beckett LA et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7(3), 280–292 (2011).
   PubMed Web of Science ®Google Scholar
• Dickerson BC, Sperling RA. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease. NeuroRx 2(2), 348–360 (2005).
   PubMedGoogle Scholar
• Hommet C, Mondon K, Constans T et al. Review of cerebral microangiopathy and Alzheimer’s disease: relation between white matter hyperintensities and microbleeds. Dement. Geriatr. Cogn. Disord. 32(6), 367–378 (2011).
   PubMedGoogle Scholar
• Admiraal-Behloul F, van den Heuvel DM, Olofsen H et al. Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage 28(3), 607–617 (2005).
   PubMedGoogle Scholar
• Gold BT, Powell DK, Andersen AH, Smith CD. Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer’s disease. Neuroimage 52(4), 1487–1494 (2010).
   PubMedGoogle Scholar
• Longstreth WT Jr, Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27(8), 1274–1282 (1996).
   PubMed Web of Science ®Google Scholar
• Schmidt R, Schmidt H, Haybaeck J et al. Heterogeneity in age-related white matter changes. Acta Neuropathol. 122(2), 171–185 (2011).
   PubMed Web of Science ®Google Scholar
• Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR. Am. J. Roentgenol. 149(2), 351–356 (1987).
   PubMed Web of Science ®Google Scholar
• Wahlund LO, Barkhof F, Fazekas F et al.; European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32(6), 1318–1322 (2001).
   PubMed Web of Science ®Google Scholar
• Brickman AM, Sneed JR, Provenzano FA et al. Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res. 193(2), 101–106 (2011).
   PubMed Web of Science ®Google Scholar
• Rostrup E, Gouw AA, Vrenken H et al.; LADIS study group. The spatial distribution of age-related white matter changes as a function of vascular risk factors – results from the LADIS study. Neuroimage 60(3), 1597–1607 (2012).
   PubMed Web of Science ®Google Scholar
• Gouw AA, Seewann A, van der Flier WM et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J. Neurol. Neurosurg. Psychiatr. 82(2), 126–135 (2011).
   PubMed Web of Science ®Google Scholar
• Simpson JE, Fernando MS, Clark L et al.; MRC Cognitive Function and Ageing Neuropathology Study Group. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol. Appl. Neurobiol. 33(4), 410–419 (2007).
   PubMed Web of Science ®Google Scholar
• Simpson JE, Ince PG, Higham CE et al.; MRC Cognitive Function and Ageing Neuropathology Study Group. Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol. Appl. Neurobiol. 33(6), 670–683 (2007).
   PubMedGoogle Scholar
• Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int. J. Obes. Relat. Metab. Disord. 27(2), 260–268 (2003).
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Three postulates to help identify the cause of Alzheimer’s disease. J. Alzheimers Dis. 24(4), 657–668 (2011).
   PubMedGoogle Scholar
• O’Brien JT, Erkinjuntti T, Reisberg B et al. Vascular cognitive impairment. Lancet Neurol. 2(2), 89–98 (2003).
   PubMed Web of Science ®Google Scholar
• Hachinski VC, Iliff LD, Zilhka E et al. Cerebral blood flow in dementia. Arch. Neurol. 32(9), 632–637 (1975).
   PubMed Web of Science ®Google Scholar
• Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke 14(3), 399–401 (1983).
   PubMed Web of Science ®Google Scholar
• Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann. Neurol. 7(5), 486–488 (1980).
   PubMed Web of Science ®Google Scholar
• Moroney JT, Bagiella E, Desmond DW et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 49(4), 1096–1105 (1997).
   PubMed Web of Science ®Google Scholar
• Brewster PW, McDowell I, Moineddin R, Tierney MC. Differential prediction of vascular dementia and Alzheimer’s disease in nondemented older adults within 5 years of initial testing. Alzheimers. Dement. 8(6), 528–535 (2012).
   PubMedGoogle Scholar
• Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 14(2), 224–232 (2000).
   PubMed Web of Science ®Google Scholar
• Hedden T, Mormino EC, Amariglio RE et al. Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J. Neurosci. 32(46), 16233–16242 (2012).
   PubMedGoogle Scholar
• Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J. Neurol. Neurosurg. Psychiatr. 79(6), 619–624 (2008).
   PubMed Web of Science ®Google Scholar
• Tamashiro JH, Zung S, Zanetti MV et al. Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar Disord. 10(7), 765–775 (2008).
   PubMed Web of Science ®Google Scholar
• Marchant NL, Reed BR, Sanossian N et al. The aging brain and cognition: contribution of vascular injury and Aβ to mild cognitive dysfunction. JAMA Neurol. 70(4), 488–495 (2013).
   PubMedGoogle Scholar
• Wahlund LO, Almkvist O, Basun H, Julin P. MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of life. Magn. Reson. Imaging 14(6), 601–608 (1996).
   PubMedGoogle Scholar
• Murray ME, Senjem ML, Petersen RC et al. Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Arch. Neurol. 67(11), 1379–1385 (2010).
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580), 353–356 (2002).
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18(4), 351–357 (1997).
   PubMed Web of Science ®Google Scholar
• Price JL, Morris JC. Tangles and plaques in nondemented aging and ‘preclinical’ Alzheimer’s disease. Ann. Neurol. 45(3), 358–368 (1999).
   PubMed Web of Science ®Google Scholar
• Ferreira LK, Busatto GF. Neuroimaging in Alzheimer’s disease: current role in clinical practice and potential future applications. Clinics (Sao. Paulo). 66(Suppl. 1), 19–24 (2011).
   PubMedGoogle Scholar
• Provenzano FA, Muraskin J, Tosto G et al.; for the Alzheimer’s Disease Neuroimaging Initiative. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol. 70(4), 455–461 (2013).
   PubMedGoogle Scholar
• Carmichael O, Schwarz C, Drucker D et al.; Alzheimer’s Disease Neuroimaging Initiative. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch. Neurol. 67(11), 1370–1378 (2010).
   PubMed Web of Science ®Google Scholar
• Brickman AM, Provenzano FA, Muraskin J et al. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch. Neurol. 69(12), 1621–1627 (2012).
   PubMedGoogle Scholar
• Gorelick PB, Scuteri A, Black SE et al.; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(9), 2672–2713 (2011).
   PubMed Web of Science ®Google Scholar
• Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341, c3666 (2010).
   PubMed Web of Science ®Google Scholar
• Mechelli A, Price CJ, Friston KJ, Ashburner J. Voxel-based morphometry of the human brain: methods and applications. Curr. Med. Imag. Rev. 1(2), 105–113 (2005).
   Web of Science ®Google Scholar
• Busatto GF, Diniz BS, Zanetti MV. Voxel-based morphometry in Alzheimer’s disease. Expert Rev. Neurother. 8(11), 1691–1702 (2008).
   PubMedGoogle Scholar
• Whitwell JL. Voxel-based morphometry: an automated technique for assessing structural changes in the brain. J. Neurosci. 29(31), 9661–9664 (2009).
   PubMed Web of Science ®Google Scholar
• Chaim TM, Duran FL, Uchida RR, Périco CA, de Castro CC, Busatto GF. Volumetric reduction of the corpus callosum in Alzheimer’s disease in vivo as assessed with voxel-based morphometry. Psychiatry Res. 154(1), 59–68 (2007).
   PubMedGoogle Scholar
• Balthazar ML, Yasuda CL, Pereira FR, Pedro T, Damasceno BP, Cendes F. Differences in grey and white matter atrophy in amnestic mild cognitive impairment and mild Alzheimer’s disease. Eur. J. Neurol. 16(4), 468–474 (2009).
   PubMedGoogle Scholar
• Busatto GF, Garrido GE, Almeida OP et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease. Neurobiol. Aging 24(2), 221–231 (2003).
   PubMed Web of Science ®Google Scholar
• Balthazar ML, Yasuda CL, Cendes F, Damasceno BP. Learning, retrieval, and recognition are compromised in aMCI and mild AD: are distinct episodic memory processes mediated by the same anatomical structures? J. Int. Neuropsychol. Soc. 16(1), 205–209 (2010).
   PubMed Web of Science ®Google Scholar
• Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV. Neurostructural predictors of Alzheimer’s disease: a meta-analysis of VBM studies. Neurobiol. Aging 32(10), 1733–1741 (2011).
   PubMed Web of Science ®Google Scholar
• Li J, Pan P, Huang R, Shang H. A meta-analysis of voxel-based morphometry studies of white matter volume alterations in Alzheimer’s disease. Neurosci. Biobehav. Rev. 36(2), 757–763 (2012).
   PubMed Web of Science ®Google Scholar
• Di Paola M, Luders E, Di Iulio F et al. Callosal atrophy in mild cognitive impairment and Alzheimer’s disease: different effects in different stages. Neuroimage 49(1), 141–149 (2010).
   PubMedGoogle Scholar
• Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Möller HJ. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer’s disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J. Neural Transm. 109(5–6), 837–855 (2002).
   PubMed Web of Science ®Google Scholar
• Teipel SJ, Bayer W, Alexander GE et al. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer’s disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol. Aging 24(1), 85–94 (2003).
   PubMedGoogle Scholar
• Teipel SJ, Bayer W, Alexander GE et al. Progression of corpus callosum atrophy in Alzheimer disease. Arch. Neurol. 59(2), 243–248 (2002).
   PubMedGoogle Scholar
• Li S, Pu F, Shi F, Xie S, Wang Y, Jiang T. Regional white matter decreases in Alzheimer’s disease using optimized voxel-based morphometry. Acta Radiol. 49(1), 84–90 (2008).
   PubMed Web of Science ®Google Scholar
• Matsuda H. Voxel-based morphometry of brain MRI in normal aging and Alzheimer’s disease. Aging Dis. 4(1), 29–37 (2013).
   PubMed Web of Science ®Google Scholar
• Di Paola M, Spalletta G, Caltagirone C. In vivo structural neuroanatomy of corpus callosum in Alzheimer’s disease and mild cognitive impairment using different MRI techniques: a review. J. Alzheimers Dis. 20(1), 67–95 (2010).
   PubMedGoogle Scholar
• Stoub TR, deToledo-Morrell L, Stebbins GT, Leurgans S, Bennett DA, Shah RC. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer’s disease. Proc. Natl Acad. Sci. USA 103(26), 10041–10045 (2006).
   PubMed Web of Science ®Google Scholar
• Guo X, Wang Z, Li K et al. Voxel-based assessment of gray and white matter volumes in Alzheimer’s disease. Neurosci. Lett. 468(2), 146–150 (2010).
   PubMedGoogle Scholar
• Villain N, Desgranges B, Viader F et al. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer’s disease. J. Neurosci. 28(24), 6174–6181 (2008).
   PubMed Web of Science ®Google Scholar
• Pereira JM, Xiong L, Acosta-Cabronero J, Pengas G, Williams GB, Nestor PJ. Registration accuracy for VBM studies varies according to region and degenerative disease grouping. Neuroimage 49(3), 2205–2215 (2010).
   PubMedGoogle Scholar
• Davatzikos C, Vaillant M, Resnick SM, Prince JL, Letovsky S, Bryan RN. A computerized approach for morphological analysis of the corpus callosum. J. Comput. Assist. Tomogr. 20(1), 88–97 (1996).
   PubMedGoogle Scholar
• Leporé N, Brun C, Pennec X et al. Mean template for tensor-based morphometry using deformation tensors. Med. Image Comput. Comput. Assist. Interv. 10(Pt 2), 826–833 (2007).
   PubMedGoogle Scholar
• Friese U, Meindl T, Herpertz SC, Reiser MF, Hampel H, Teipel SJ. Diagnostic utility of novel MRI-based biomarkers for Alzheimer’s disease: diffusion tensor imaging and deformation-based morphometry. J. Alzheimers Dis. 20(2), 477–490 (2010).
   PubMedGoogle Scholar
• Fischl B. FreeSurfer. Neuroimage 62(2), 774–781 (2012).
   PubMed Web of Science ®Google Scholar
• Westman E, Muehlboeck JS, Simmons A. Combining MRI and CSF measures for classification of Alzheimer’s disease and prediction of mild cognitive impairment conversion. Neuroimage 62(1), 229–238 (2012).
   PubMed Web of Science ®Google Scholar
• Ridgway GR, Lehmann M, Barnes J et al. Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology 79(1), 80–84 (2012).
   PubMed Web of Science ®Google Scholar
• Salat DH, Greve DN, Pacheco JL et al. Regional white matter volume differences in nondemented aging and Alzheimer’s disease. Neuroimage 44(4), 1247–1258 (2009).
   PubMed Web of Science ®Google Scholar
• Clarkson MJ, Cardoso MJ, Ridgway GR et al. A comparison of voxel and surface based cortical thickness estimation methods. Neuroimage 57(3), 856–865 (2011).
   PubMedGoogle Scholar
• Masutani Y, Aoki S, Abe O, Hayashi N, Otomo K. MR diffusion tensor imaging: recent advance and new techniques for diffusion tensor visualization. Eur. J. Radiol. 46(1), 53–66 (2003).
   PubMed Web of Science ®Google Scholar
• Yoon B, Shim YS, Hong YJ et al. Comparison of diffusion tensor imaging and voxel-based morphometry to detect white matter damage in Alzheimer’s disease. J. Neurol. Sci. 302(1–2), 89–95 (2011).
   PubMedGoogle Scholar
• Sydykova D, Stahl R, Dietrich O et al. Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer’s disease: a diffusion tensor imaging and voxel-based morphometry study. Cereb. Cortex 17(10), 2276–2282 (2007).
   PubMedGoogle Scholar
• Mielke MM, Kozauer NA, Chan KC et al. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer’s disease. Neuroimage 46(1), 47–55 (2009).
   PubMed Web of Science ®Google Scholar
• Cho H, Yang DW, Shon YM et al. Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study. J. Korean Med. Sci. 23(3), 477–483 (2008).
   PubMed Web of Science ®Google Scholar
• Salat DH, Tuch DS, van der Kouwe AJ et al. White matter pathology isolates the hippocampal formation in Alzheimer’s disease. Neurobiol. Aging 31(2), 244–256 (2010).
   PubMed Web of Science ®Google Scholar
• O’Dwyer L, Lamberton F, Bokde AL et al. Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer’s disease. PLoS ONE 6(6), e21745 (2011).
   Google Scholar
• Alves GS, O’Dwyer L, Jurcoane A et al. Different patterns of white matter degeneration using multiple diffusion indices and volumetric data in mild cognitive impairment and Alzheimer patients. PLoS ONE 7(12), e52859 (2012).
   PubMed Web of Science ®Google Scholar
• Stricker NH, Schweinsburg BC, Delano-Wood L et al. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer’s disease supports retrogenesis. Neuroimage 45(1), 10–16 (2009).
   PubMed Web of Science ®Google Scholar
• Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer’s disease. Neurobiol. Aging 32(12), 2322.e5–2322.18 (2011).
   Google Scholar
• Clerx L, Visser PJ, Verhey F, Aalten P. New MRI markers for Alzheimer’s disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements. J. Alzheimers Dis. 29(2), 405–429 (2012).
   PubMedGoogle Scholar
• Shu N, Wang Z, Qi Z, Li K, He Y. Multiple diffusion indices reveals white matter degeneration in Alzheimer’s disease and mild cognitive impairment: a tract-based spatial statistics study. J. Alzheimers Dis. 26(Suppl. 3), 275–285 (2011).
   PubMedGoogle Scholar
• Mielke MM, Okonkwo OC, Oishi K et al. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer’s disease. Alzheimers. Dement. 8(2), 105–113 (2012).
   PubMedGoogle Scholar
• Kalus P, Slotboom J, Gallinat J et al. Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. Neuroimage 30(3), 713–720 (2006).
   PubMedGoogle Scholar
• Wang J, Zuo X, Dai Z et al. Disrupted functional brain connectome in individuals at risk for Alzheimer’s disease. Biol. Psychiatr. 73(5), 472–481. (2012).
   PubMedGoogle Scholar
• Heinemann U, Schmitz D, Eder C, Gloveli T. Properties of entorhinal cortex projection cells to the hippocampal formation. Ann. N. Y. Acad. Sci. 911, 112–126 (2000).
   PubMedGoogle Scholar
• Witter MP. The perforant path: projections from the entorhinal cortex to the dentate gyrus. Prog. Brain Res. 163, 43–61 (2007).
   PubMedGoogle Scholar
• Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer’s disease. Ann. Neurol. 20(4), 472–481 (1986).
   PubMed Web of Science ®Google Scholar
• Morys J, Sadowski M, Barcikowska M, Maciejewska B, Narkiewicz O. The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer’s disease. Acta Neurobiol. Exp. (Wars) 54(1), 47–53 (1994).
   PubMedGoogle Scholar
• Xie S, Xiao JX, Gong GL et al. Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology 66(12), 1845–1849 (2006).
   PubMed Web of Science ®Google Scholar
• Smith SM, Jenkinson M, Johansen-Berg H et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31(4), 1487–1505 (2006).
   PubMed Web of Science ®Google Scholar
• van Bruggen T, Stieltjes B, Thomann PA, Parzer P, Meinzer HP, Fritzsche KH. Do Alzheimer-specific microstructural changes in mild cognitive impairment predict conversion? Psychiatry Res. 203(2–3), 184–193 (2012).
   PubMed Web of Science ®Google Scholar
• Zhuang L, Wen W, Zhu W et al. White matter integrity in mild cognitive impairment: a tract-based spatial statistics study. Neuroimage 53(1), 16–25 (2010).
   PubMed Web of Science ®Google Scholar
• Liu Y, Spulber G, Lehtimäki KK et al. Diffusion tensor imaging and tract-based spatial statistics in Alzheimer’s disease and mild cognitive impairment. Neurobiol. Aging 32(9), 1558–1571 (2011).
   PubMed Web of Science ®Google Scholar
• Jones DK, Knösche TR, Turner R. White matter integrity, fiber count, and other fallacies: the do’s and don’ts of diffusion MRI. Neuroimage 73, 239–254 (2013).
   PubMed Web of Science ®Google Scholar
• Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. DTI analyses and clinical applications in Alzheimer’s disease. J. Alzheimers Dis. 26(Suppl. 3), 287–296 (2011).
   PubMedGoogle Scholar
• Takahashi M, Hackney DB, Zhang G et al. Magnetic resonance microimaging of intraaxonal water diffusion in live excised lamprey spinal cord. Proc. Natl Acad. Sci. USA 99(25), 16192–16196 (2002).
   PubMedGoogle Scholar
• Lyketsos CG, Carrillo MC, Ryan JM et al. Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimers. Dement. 7(5), 532–539 (2011).
   PubMedGoogle Scholar
• Bruen PD, McGeown WJ, Shanks MF, Venneri A. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain 131(Pt 9), 2455–2463 (2008).
   PubMed Web of Science ®Google Scholar
• Trzepacz PT, Yu P, Bhamidipati PK et al.; Alzheimer’s Disease Neuroimaging Initiative. Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer’s disease. Alzheimers. Dement. doi:10.1016/j.jalz.2012.10.005 (2012) (Epub ahead of print).
   PubMedGoogle Scholar
• Nakaaki S, Sato J, Torii K et al. Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer’s disease: a voxel-based morphometry study. Neuropsychiatr. Dis. Treat. 9, 1–8 (2013).
   PubMed Web of Science ®Google Scholar
• Tighe SK, Oishi K, Mori S et al. Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer’s dementia. J. Neuropsychiatry Clin. Neurosci. 24(4), 484–488 (2012).
   PubMedGoogle Scholar
• Ota M, Sato N, Nakata Y, Arima K, Uno M. Relationship between apathy and diffusion tensor imaging metrics of the brain in Alzheimer’s disease. Int. J. Geriatr. Psychiatry 27(7), 722–726 (2012).
   PubMedGoogle Scholar
• Tomimoto H, Lin JX, Matsuo A et al. Different mechanisms of corpus callosum atrophy in Alzheimer’s disease and vascular dementia. J. Neurol. 251(4), 398–406 (2004).
   PubMedGoogle Scholar
• Bartzokis G. Alzheimer’s disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 32(8), 1341–1371 (2011).
   PubMed Web of Science ®Google Scholar
• Brickman AM, Meier IB, Korgaonkar MS et al. Testing the white matter retrogenesis hypothesis of cognitive aging. Neurobiol. Aging 33(8), 1699–1715 (2012).
   PubMed Web of Science ®Google Scholar
• Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease. Neurobiol. Aging 25(1), 5–18; author reply 49 (2004).
   PubMed Web of Science ®Google Scholar
• Kuceyeski A, Zhang Y, Raj A. Linking white matter integrity loss to associated cortical regions using structural connectivity information in Alzheimer’s disease and fronto-temporal dementia: the Loss in Connectivity (LoCo) score. Neuroimage 61(4), 1311–1323 (2012).
   PubMedGoogle Scholar
• Fu JL, Zhang T, Chang C, Zhang YZ, Li WB. The value of diffusion tensor imaging in the differential diagnosis of subcortical ischemic vascular dementia and Alzheimer’s disease in patients with only mild white matter alterations on T2-weighted images. Acta Radiol. 53(3), 312–317 (2012).
   PubMedGoogle Scholar
• Bozoki AC, Korolev IO, Davis NC, Hoisington LA, Berger KL. Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer’s disease: a DTI/FDG-PET study. Hum. Brain Mapp. 33(8), 1792–1802 (2012).
   PubMedGoogle Scholar
• Müller MJ, Greverus D, Weibrich C et al. Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI. Neurobiol. Aging 28(3), 398–403 (2007).
   PubMed Web of Science ®Google Scholar
• O’Dwyer L, Lamberton F, Bokde AL et al. Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment. PLoS ONE 7(2), e32441 (2012).
   PubMed Web of Science ®Google Scholar
• Wang L, Goldstein FC, Veledar E et al. Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging. AJNR. Am. J. Neuroradiol. 30(5), 893–899 (2009).
   PubMed Web of Science ®Google Scholar
• McMillan CT, Brun C, Siddiqui S et al. White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration. Neurology 78(22), 1761–1768 (2012).
   PubMedGoogle Scholar
• Likitjaroen Y, Meindl T, Friese U et al. Longitudinal changes of fractional anisotropy in Alzheimer’s disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study. Eur. Arch. Psychiatry Clin. Neurosci. 262(4), 341–350 (2012).
   PubMed Web of Science ®Google Scholar
• Jack CR Jr, Bernstein MA, Borowski BJ et al.; Alzheimer’s Disease Neuroimaging Initiative. Update on the magnetic resonance imaging core of the Alzheimer’s disease neuroimaging initiative. Alzheimers. Dement. 6(3), 212–220 (2010).
   PubMed Web of Science ®Google Scholar
• Jack CR Jr. Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology 263(2), 344–361 (2012).
   PubMed Web of Science ®Google Scholar
• Yassa MA, Muftuler LT, Stark CE. Ultrahigh-resolution microstructural diffusion tensor imaging reveals perforant path degradation in aged humans in vivo. Proc. Natl Acad. Sci. USA 107(28), 12687–12691 (2010).
   PubMedGoogle Scholar
• Greicius MD, Supekar K, Menon V, Dougherty RF. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb. Cortex 19(1), 72–78 (2009).
   PubMed Web of Science ®Google Scholar
• Chételat G, Desgranges B, Landeau B et al. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer’s disease. Brain 131(Pt 1), 60–71 (2008).
   PubMedGoogle Scholar
• Jacobs HI, Gronenschild EH, Evers EA et al. Visuospatial processing in early Alzheimer’s disease: a multimodal neuroimaging study. Cortex. doi:10.1016/j.cortex.2012.01.005 (2012) (Epub ahead of print).
   Google Scholar
• Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network: anatomy, function, and relevance to disease. Ann. N. Y. Acad. Sci. 1124, 1–38 (2008).
   PubMed Web of Science ®Google Scholar
• Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc. Natl Acad. Sci. USA 98(2), 676–682 (2001).
   PubMed Web of Science ®Google Scholar
• Kantarci K, Lowe VJ, Boeve BF et al. Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol. Aging 33(9), 2091–2105 (2012).
   PubMed Web of Science ®Google Scholar
• Shaffer JL, Petrella JR, Sheldon FC et al.; Alzheimer’s Disease Neuroimaging Initiative. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 266(2), 583–591 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang D, Shen D. Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLoS ONE 7(3), e33182 (2012).
   PubMed Web of Science ®Google Scholar
• Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer’s disease. Neuron 63(3), 287–303 (2009).
   PubMed Web of Science ®Google Scholar
• Chiang GC, Zhan W, Schuff N, Weiner MW. White matter alterations in cognitively normal apoE e2 carriers: insight into Alzheimer resistance? AJNR. Am. J. Neuroradiol. 33(7), 1392–1397 (2012).
   PubMed Web of Science ®Google Scholar
• Forlenza OV, Diniz BS, Gattaz WF. Diagnosis and biomarkers of predementia in Alzheimer’s disease. BMC Med. 8, 89 (2010).
   PubMed Web of Science ®Google Scholar
• Hu WT, Holtzman DM, Fagan AM et al.; Alzheimer’s Disease Neuroimaging Initiative. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 79(9), 897–905 (2012).
   PubMed Web of Science ®Google Scholar
• Mielke MM, Haughey NJ, Ratnam Bandaru VV et al. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers. Dement. 6(5), 378–385 (2010).
   PubMed Web of Science ®Google Scholar
• Vemuri P, Wiste HJ, Weigand SD et al.; Alzheimer’s Disease Neuroimaging Initiative. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 73(4), 294–301 (2009).
   PubMed Web of Science ®Google Scholar
• Thambisetty M, An Y, Kinsey A et al. Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage 59(1), 212–217 (2012).
   PubMed Web of Science ®Google Scholar